Early and sustained increase in time in range 1 year after initiation of hybrid close loop therapy via telemedicine in type 1 diabetes patients

BACKGROUND AND AIMS: Evidence supports the efficacy and safety of the Hybrid Close loop (HCL) system in patients with type 1 diabetes (T1D). However, limited data are available on the long-term outcomes of patients on HCL with telemedicine follow-up. METHODS: A prospective observational cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Ana M., Henao, Diana, Parra, Darío, Kerguelen, Alfonso, Jaramillo, Pablo, Gómez, Yaline, Muñoz, Oscar Mauricio, Rondón, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068726/
https://www.ncbi.nlm.nih.gov/pubmed/37010594
http://dx.doi.org/10.1007/s00592-023-02051-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068726/
https://www.ncbi.nlm.nih.gov/pubmed/37010594
http://dx.doi.org/10.1007/s00592-023-02051-w

Ejemplares similares